Regulation and Function of Adiponectin Oligomerization

脂联素寡聚化的调控和功能

基本信息

  • 批准号:
    8697171
  • 负责人:
  • 金额:
    $ 33.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

Abstract Impaired endoplasmic reticulum (ER) and mitochondrial function has been implicated in many of the obesity-induced etiology of insulin resistance and type 2 diabetes. However, the underlying molecular mechanisms remain to be fully elucidated. We have identified Disulfide bond A oxidoreductase-like protein or DsbA-L as a critical regulator of adiponectin assembly and secretion in adipocytes (Liu et al (2008) Proc. Nat. Acad. Sci. USA, 105, 18302-07). DsbA-L expression in adipose tissues is significantly reduced in obese human subjects and animal models of obesity. In addition, fat-specific overexpression of DsbA-L promoted adiponectin multimerization in vivo and reduced high fat diet-induced insulin resistance and hepatosteatosis via an adiponectin-dependent mechanism (Liu et al. (2012) Diabetes, 61, 2776-86). However, how DsbA-L improves insulin resistance and energy homeostasis remains unknown. A novel observation made in our preliminary study is that DsbA-L is localized in both the ER and mitochondria. In addition, we have found that fat-specific knockout of DsbA-L led to suppressed adiponectin multimerization and abundance, impaired ER and mitochondrial function, decreased UCP1 and other brown gene expression in adipose tissues, and reduced energy expenditure. Taken together, these results suggest that DsbA-L may exert its anti-obesity and insulin sensitizing roles by promoting adiponectin biosynthesis and thermogenesis, which may be mediated by improving the integrity and function of both the ER and mitochondria. We will test this hypothesis by using in vitro and ex vivo approaches as well as fat-specific DsbA-L overexpression or knockout mouse models. This research will further our understanding of the mechanisms underlying obesity-induced insulin resistance and dysregulation of energy homeostasis. Results from this study will also lead to the identification of new drug target(s) for innovative therapeutic strategies to prevent obesity-induced metabolic disorders.
摘要 受损的内质网(ER)和线粒体功能已被牵连在许多 肥胖引起的胰岛素抵抗和2型糖尿病的病因。然而,潜在的分子 机制仍有待充分阐明。我们已经鉴定出二硫键A氧化还原酶样蛋白或 DsbA-L作为脂肪细胞中脂联素组装和分泌的关键调节剂(Liu等人(2008)Proc. Nat. Acad. Sci. USA,105,18302-07)。肥胖者脂肪组织中DsbA-L表达显著降低 受试者和肥胖动物模型。此外,脂肪特异性过表达DsbA-L促进脂联素 在体内多聚化,并减少高脂饮食诱导的胰岛素抵抗和脂肪肝, 脂联素依赖性机制(Liu等人(2012)Diabetes,61,2776-86)。然而,DsbA-L如何改善 胰岛素抵抗和能量稳态仍然是未知的。 在我们的初步研究中,一个新的观察结果是DsbA-L定位于ER和 线粒体此外,我们发现脂肪特异性敲除DsbA-L导致脂联素抑制, 多聚化和丰度,ER和线粒体功能受损,UCP 1和其他棕色 脂肪组织中的基因表达,并减少能量消耗。综合来看,这些结果表明 DsbA-L可能通过促进脂联素的生物合成而发挥其抗肥胖和胰岛素增敏作用, 产热,这可能是通过改善ER和线粒体的完整性和功能来介导的。 我们将使用体外和离体方法以及脂肪特异性DsbA-L 过表达或敲除小鼠模型。这项研究将进一步加深我们对这些机制的理解。 潜在的肥胖诱导的胰岛素抵抗和能量稳态失调。本研究结果 还将导致确定新的药物靶点,用于创新的治疗策略, 肥胖引起的代谢紊乱

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FENG LIU其他文献

FENG LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FENG LIU', 18)}}的其他基金

Regulation of Adipose Tissue Function by Grb10
Grb10 对脂肪组织功能的调节
  • 批准号:
    8884599
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Regulation of Adipose Tissue Function by Grb10
Grb10 对脂肪组织功能的调节
  • 批准号:
    9095352
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Regulation of Adipose Tissue Function by Grb10
Grb10 对脂肪组织功能的调节
  • 批准号:
    8612836
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Regulation of Adipose Tissue Function by Grb10
Grb10 对脂肪组织功能的调节
  • 批准号:
    8733684
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Nanocrystals for the Treatment of Multidrug Resistance in Cancer
用于治疗癌症多药耐药性的纳米晶体
  • 批准号:
    8321471
  • 财政年份:
    2011
  • 资助金额:
    $ 33.85万
  • 项目类别:
Nanocrystals for the Treatment of Multidrug Resistance in Cancer
用于治疗癌症多药耐药性的纳米晶体
  • 批准号:
    8493793
  • 财政年份:
    2011
  • 资助金额:
    $ 33.85万
  • 项目类别:
Nanocrystals for the Treatment of Multidrug Resistance in Cancer
用于治疗癌症多药耐药性的纳米晶体
  • 批准号:
    8038042
  • 财政年份:
    2011
  • 资助金额:
    $ 33.85万
  • 项目类别:
Regulation and Function of Adiponectin Oligomerization
脂联素寡聚化的调控和功能
  • 批准号:
    7997090
  • 财政年份:
    2009
  • 资助金额:
    $ 33.85万
  • 项目类别:
Regulation and Function of Adiponectin Oligomerization
脂联素寡聚化的调控和功能
  • 批准号:
    7585784
  • 财政年份:
    2008
  • 资助金额:
    $ 33.85万
  • 项目类别:
Regulation and Function of Adiponectin Oligomerization
脂联素寡聚化的调控和功能
  • 批准号:
    8827760
  • 财政年份:
    2008
  • 资助金额:
    $ 33.85万
  • 项目类别:

相似国自然基金

相似海外基金

Recruitment of brown adipocytes in visceral white adipose tissue by fibroblast growth factor 8b
成纤维细胞生长因子 8b 将棕色脂肪细胞募集到内脏白色脂肪组织中
  • 批准号:
    321208980
  • 财政年份:
    2016
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Research Grants
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8827438
  • 财政年份:
    2014
  • 资助金额:
    $ 33.85万
  • 项目类别:
Induction of brown-like adipocytes in white adipose tissue by food-derived factors
食物源性因子在白色脂肪组织中诱导棕色样脂肪细胞
  • 批准号:
    26450168
  • 财政年份:
    2014
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
WAT-on-a-chip - Development of a micofluidic, microphysiologic in vitro adipose tissue model for high-throughput drug screening based on hiPSC-derived adipocytes.
WAT-on-a-chip - 开发微流体、微生理体外脂肪组织模型,用于基于 hiPSC 衍生脂肪细胞的高通量药物筛选。
  • 批准号:
    257256526
  • 财政年份:
    2014
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Research Fellowships
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8828181
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8520690
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8629741
  • 财政年份:
    2013
  • 资助金额:
    $ 33.85万
  • 项目类别:
Effect of exercise training on formation of brite adipocytes within white adipose tissue
运动训练对白色脂肪组织内脂肪细胞形成的影响
  • 批准号:
    23700778
  • 财政年份:
    2011
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation for the mechanisms of the emergence of brown adipocytes in white adipose tissue
白色脂肪组织中棕色脂肪细胞出现机制的研究
  • 批准号:
    21780261
  • 财政年份:
    2009
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
LOUISIANA COBRE: P1: INDUCE THERMOGENIC BROWN ADIPOCYTES IN WHITE ADIPOSE TISSUE
路易斯安那 COBRE:P1:在白色脂肪组织中诱导产热棕色脂肪细胞
  • 批准号:
    7610781
  • 财政年份:
    2007
  • 资助金额:
    $ 33.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了